🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,99 USD

Máx. histórico

178,74

2143 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,38%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+2,43%

Cierre anterior

18,54

Rango de hoy

18,52 – 19,26

Volumen hoy

1.328.200

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 1 día
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/07/2002 18,78 18,78 17,10 18,00 -0,66% 8,95% 13.800
09/07/2002 18,30 18,30 16,56 18,12 +2,72% 9,51% 27.450
08/07/2002 17,94 18,42 16,62 17,64 -3,92% 10,03% 20.617
05/07/2002 15,90 18,36 15,90 18,36 +11,68% 15,47% 12.767
03/07/2002 17,40 17,76 15,96 16,44 -2,49% 10,34% 19.633
02/07/2002 17,82 18,24 16,86 16,86 -3,44% 7,74% 27.050
01/07/2002 19,38 19,38 17,40 17,46 -1,02% 10,22% 26.800
28/06/2002 19,98 20,52 16,50 17,64 -9,54% 20,12% 178.583
27/06/2002 19,38 19,98 18,90 19,50 +4,17% 5,57% 17.800
26/06/2002 18,66 19,20 17,10 18,72 +0,65% 11,25% 15.433
25/06/2002 20,70 23,70 18,30 18,60 -11,93% 26,09% 35.517
24/06/2002 21,72 22,44 19,50 21,12 -4,35% 13,54% 22.900
21/06/2002 23,34 23,46 21,12 22,08 -1,87% 10,03% 19.000
20/06/2002 23,52 25,50 21,72 22,50 +1,08% 16,07% 43.567
19/06/2002 23,82 26,64 21,00 22,26 -6,78% 23,68% 64.317
18/06/2002 21,60 24,00 21,18 23,88 +13,71% 13,06% 44.867
17/06/2002 18,48 21,60 18,42 21,00 +15,51% 17,21% 53.433
14/06/2002 16,50 18,96 15,42 18,18 +12,64% 21,45% 69.400
13/06/2002 16,14 17,28 15,48 16,14 -2,18% 11,15% 61.417
12/06/2002 17,70 18,06 15,90 16,50 -8,94% 12,20% 50.900
11/06/2002 20,04 20,64 17,34 18,12 -9,31% 16,47% 40.067
10/06/2002 22,56 22,56 19,98 19,98 -8,01% 11,44% 19.567
07/06/2002 19,20 21,78 18,72 21,72 -1,09% 15,94% 53.350
06/06/2002 23,40 23,70 21,90 21,96 -7,11% 7,69% 43.217
05/06/2002 25,14 26,28 22,92 23,64 -2,72% 13,37% 29.750
04/06/2002 26,88 26,94 21,96 24,30 -5,81% 18,53% 59.150
03/06/2002 28,26 29,10 25,50 25,80 -11,34% 12,74% 27.317
31/05/2002 27,90 29,40 26,46 29,10 +8,02% 10,54% 27.750
30/05/2002 27,96 28,44 25,80 26,94 -2,60% 9,44% 41.800
29/05/2002 30,06 30,90 27,60 27,66 -9,43% 10,98% 50.633